Circulating Inflammatory Factor Levels in the Early Phase of COVID-19 are Associated with the Progression of Respiratory Failure: A Single-Center Retrospective Study

References

• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Chan M, Vijay S, McNevin J, et al. Machine learning identifies molecular regulators and therapeutics for targeting SARS-CoV2-induced cytokine release. Mol Syst Biol. 2021;17(9):e10426. doi:10.15252/msb.202110426
   PubMed Web of Science ®Google Scholar
• Chan M, Holland EC, Gujral TS. Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release in human peripheral blood mononuclear cells. EMBO Mol Med. 2022;14(6):e15919. doi:10.15252/emmm.202215919
   PubMed Web of Science ®Google Scholar
• Monteleone G, Sarzi-Puttini PC, Ardizzone S. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol. 2020;2(5):e255–e256. doi:10.1016/S2665-9913(20)30092-8
   PubMedGoogle Scholar
• Saleki K, Alijanizadeh P, Azadmehr A. Is neuropilin-1 the neuroimmune initiator of multi-system hyperinflammation in COVID-19? Biomed Pharmacother. 2023;167:115558. doi:10.1016/j.biopha.2023.115558
   PubMed Web of Science ®Google Scholar
• Hazrati E, Gholami M, Farahani RH, et al. The effect of IGF-1 plasma concentration on COVID-19 severity. Microb Pathog. 2022;164:105416. doi:10.1016/j.micpath.2022.105416
   PubMed Web of Science ®Google Scholar
• Jafarzadeh A, Chauhan P, Saha B, et al. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: lessons from SARS and MERS, and potential therapeutic interventions. Life Sci. 2020;257:118102. doi:10.1016/j.lfs.2020.118102
   PubMed Web of Science ®Google Scholar
• Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474. doi:10.1126/science.abb8925
   PubMed Web of Science ®Google Scholar
• Wang J, Wang C. The coming Omicron waves and factors affecting its spread after China reopening borders. BMC Med Inform Decis Mak. 2023;23(1):186. doi:10.1186/s12911-023-02219-y
   PubMed Web of Science ®Google Scholar
• Xiao H, Wang Z, Liu F, et al. Excess all-cause mortality in China after ending the zero COVID policy. JAMA Netw Open. 2023;6(8):e2330877. doi:10.1001/jamanetworkopen.2023.30877
   PubMed Web of Science ®Google Scholar
• Hu W, Li X, Yan Z, et al. Impact of the first wave of COVID-19 on Crohn’s disease after the end of “zero-COVID” policy in China. Front Public Health. 2023;11:1186275. doi:10.3389/fpubh.2023.1186275
   PubMed Web of Science ®Google Scholar
• Machnicki S, Patel D, Singh A, et al. The usefulness of chest CT imaging in patients with suspected or diagnosed COVID-19: a review of literature. Chest. 2021;160(2):652–670. doi:10.1016/j.chest.2021.04.004
   PubMed Web of Science ®Google Scholar
• Ebrahimzadeh S, Islam N, Dawit H, et al. Thoracic imaging tests for the diagnosis of COVID-19. Cochrane Database Syst Rev. 2022;5(5):CD013639. doi:10.1002/14651858.CD013639.pub5
   PubMedGoogle Scholar
• Ye H, Liu ZM, Zhou L, et al. Levels of peripheral IL-6 and CD4+ and CD8+ T cells and their prognostic significance in COVID-19. Eur Rev Med Pharmacol Sci. 2023;27(6):2686–2691. doi:10.26355/eurrev_202303_31806
   PubMed Web of Science ®Google Scholar
• Ramasamy S, Subbian S. Critical determinants of cytokine storm and Type I interferon response in COVID-19 pathogenesis. Clin Microbiol Rev. 2021;34(4):e00299–20. doi:10.1128/CMR.00299-20
   PubMed Web of Science ®Google Scholar
• Qi X, Kong H, Ding W, et al. Abnormal coagulation function of patients with COVID-19 is significantly related to hypocalcemia and severe inflammation. Front Med (Lausanne). 2021;8:638194. doi:10.3389/fmed.2021.638194
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhang Y, Chi H, et al. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study. Clin Chem Lab Med. 2020;58(7):1106–1115. doi:10.1515/cclm-2020-0377
   PubMed Web of Science ®Google Scholar
• Shen L, Chen L, Chi H, et al. Parameters and morphological changes of erythrocytes and platelets of COVID-19 subjects: a longitudinal cohort study. Infect Drug Resist. 2023;16:1657–1668. doi:10.2147/IDR.S400735
   PubMed Web of Science ®Google Scholar
• Caterino M, Costanzo M, Fedele R, et al. The serum metabolome of moderate and severe COVID-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism. Int J Mol Sci. 2021;22(17):9548. doi:10.3390/ijms22179548
   PubMed Web of Science ®Google Scholar
• Lippi G, Mullier F, Favaloro EJ. D-dimer: old dogmas, new (COVID-19) tricks. Clin Chem Lab Med. 2023;61(15):841–850. doi:10.1515/cclm-2022-0633
   PubMedGoogle Scholar
• Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: incidence, pathophysiology, and management. Thromb Res. 2020;194:101–115. doi:10.1016/j.thromres.2020.06.029
   PubMed Web of Science ®Google Scholar
• Middleton EA, He XY, Denorme F, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10):1169–1179. doi:10.1182/blood.2020007008
   PubMed Web of Science ®Google Scholar
• Akbari H, Tabrizi R, Lankarani KB, et al. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Life Sci. 2020;258:118167. doi:10.1016/j.lfs.2020.118167
   PubMed Web of Science ®Google Scholar
• Filgueira TO, Carvalho PRC, de Sousa Fernandes MS, et al. The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients. Front Immunol. 2022;13:1051059. doi:10.3389/fimmu.2022.1051059
   PubMed Web of Science ®Google Scholar
• Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250–256. doi:10.1002/jmv.26232
   PubMed Web of Science ®Google Scholar
• Jones SA, Hunter CA. Is IL-6 a key cytokine target for therapy in COVID-19? Nat Rev Immunol. 2021;21(6):337–339. doi:10.1038/s41577-021-00553-8
   PubMed Web of Science ®Google Scholar
• Laguna-Goya R, Utrero-Rico A, Talayero P, et al. IL-6-based mortality risk model for hospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146(4):799–807.e9. doi:10.1016/j.jaci.2020.07.009
   PubMed Web of Science ®Google Scholar
• Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9(1):1123–1130. doi:10.1080/22221751.2020.1770129
   PubMed Web of Science ®Google Scholar
• Rotundo S, Borelli M, Scaglione V, et al. Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies. Clin Exp Med. 2023;23(1):1–7. doi:10.1007/s10238-021-00781-1
   PubMedGoogle Scholar
• Pacha O, Sallman MA, Evans SE. COVID-19: a case for inhibiting IL-17? Nat Rev Immunol. 2020;20(6):345–346. doi:10.1038/s41577-020-0328-z
   PubMed Web of Science ®Google Scholar
• Lu L, Zhang H, Dauphars DJ, He YW. A potential role of interleukin 10 in COVID-19 pathogenesis. Trends Immunol. 2021;42(1):3–5. doi:10.1016/j.it.2020.10.012
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Luo W, Zhang JW, Zhang W, Lin YL, Wang Q. Circulating levels of IL-2, IL-4, TNF-α, IFN-γ, and C-reactive protein are not associated with severity of COVID-19 symptoms. J Med Virol. 2021;93(1):89–91. doi:10.1002/jmv.26156
   PubMed Web of Science ®Google Scholar
• Bhattacharjee A, Shukla M, Yakubenko VP, Mulya A, Kundu S, Cathcart MK. IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radic Biol Med. 2013;54:1–16. doi:10.1016/j.freeradbiomed.2012.10.553
   PubMed Web of Science ®Google Scholar
• Renu K, Subramaniam MD, Chakraborty R, et al. The role of interleukin-4 in COVID-19 associated male infertility – a hypothesis. J Reprod Immunol. 2020;142:103213. doi:10.1016/j.jri.2020.103213
   PubMed Web of Science ®Google Scholar